News
WHO approves India COVID vaccine for emergency use
The World Health Organization has granted approval for emergency use to India’s government-backed Covid-19 vaccine, Covaxin
India’s vaccine was approved for use within India back in January while the third phase of clinical trials was still under way, sparking some concern and criticism.
The company that produces the vaccine, Bharat Biotech, has since published data suggesting 78% efficacy against the COVID-19 vaccine.
The WHO stated in a tweet it believed the benefits far outweighed the risks associated with the jab
“200 percent safe”
Some experts had pointed to a fast-track approval and incomplete data, but the firm’s chairman, Dr Krishna Ella, stated the vaccine was “200% safe”.
The expert panel World Health Organizations, which authorises emergency approvals, had asked for more data last month while examining the application Bharat Biotech had filed in July.
The approval comes as a major relief to the tens of millions of Indians who have already received the jab.
India has administered more than 105 million Covaxin doses so far – and a fillip for Bharat Biotech.
Few countries have recognised Covaxin and India hopes the WHO approval will change that.
How that will play out on travel restrictions for vaccinated Indians remains unclear.
Covishield is basically the Indian-made version of Astrazeneca and remains the most popular jab in the country, accounting for most of India’s 810 million jabs.
The vaccine has been approved by the WHO but the UK recognised the jab only after a refusal to do so sparked anger in India.
News
Tensions rise as Iran threatens conflict and U.S. increases naval forces
Iran warns of regional conflict, labels European armies terrorists; U.S. boosts naval presence as both sides consider negotiations.
Iran warns of regional conflict, labels European armies terrorists; U.S. boosts naval presence as both sides consider negotiations.
Iran has warned of a potential regional conflict if the U.S. launches an attack, while labelling European armies as terrorists. Supreme Leader Ayatollah Ali Khamenei insisted that threats from President Trump will not intimidate the Iranian people.
The U.S. has ramped up its naval presence in the Middle East in response to mounting threats, amid speculation over Iran’s next moves. Iranian officials have denied claims of imminent naval exercises in the Strait of Hormuz, adding to global uncertainty.
News
Carlos Alcaraz becomes youngest man to complete career Grand Slam
Carlos Alcaraz, at 22, stuns tennis by winning the Australian Open, defeating Djokovic, and celebrating with a kangaroo tattoo.
Carlos Alcaraz, at 22, stuns tennis by winning the Australian Open, defeating Djokovic, and celebrating with a kangaroo tattoo.
Carlos Alcaraz has stunned the tennis world by winning the Australian Open, becoming the youngest man to complete a Career Grand Slam at just 22 years old.
The world number one beat Novak Djokovic in a thrilling four-set match, finishing 2-6, 6-2, 6-3, 7-5. Djokovic missed out on claiming his 25th Grand Slam title. To mark the milestone, Alcaraz revealed he plans to add a new tattoo of a kangaroo on his leg, joining his existing Eiffel Tower and Wimbledon strawberry tattoos.
#CarlosAlcaraz #AustralianOpen #GrandSlam #TennisHistory #NovakDjokovic #SportsNews #TennisTattoo #YoungChampion
-
Ticker Views4 days agoHow Iran is powering Russia’s next generation drone war
-
Shows15 hours ago
How AI is transforming real estate investment strategies
-
News4 days ago
Big Tech earnings spark investor unease over AI spending
-
Crypto5 days ago
White House holds talks with crypto and banking executives on new rules
-
Ticker Views5 days ago
Australia inflation, USD volatility and Fed dissent explained
-
Money3 days ago
U.S. dollar weakens while Australian dollar rises amid global market shifts
-
News5 days ago
Federal Reserve holds interest rates amid economic uncertainty
-
News5 days ago
Trump warns Iran as U.S. naval forces approach amid rising tensions
